FDA Approves Tecentriq Hybreza for Subcutaneous Injection for All Adult Indications of IV Tecentriq

The FDA has approved Tecentriq Hybreza for subcutaneous injection as the intravenous formulation of Tecentriq.

SEPTEMBER 16, 2024